Event Details

« Back

Immatics presenting at Hanson Wade CAR TCR Digital Week

Sep 14 - Sep 17, 2020

Join us and others in the cell immunotherapy revolution to engineer a cancer-free world. Let’s e-meet during the CAR-TCR Digital Week (Virtual Event, September 14-17) and discuss recent advances from discovery, clinical trials through to late-stage manufacturing.

Monday, September 14, 11.35am PDT (2.35pm EDT/ 8.35pm CEST)

Session: Innovative Target Identification to Define Clinically Beneficial & Safe Targets

Presentation: TCR-T Therapies Using Novel Solid Cancer Targets

  • TCR-T Therapies for Solid Tumors Using Novel Targets
  • Assess the discovery, characterization and engineering of TCRs using the XCEPTORTM platform directed against novel targets derived from the XPRESIDENT® platform
  • Preclinical Update on Immatics’ ACTengine® program IMA204

Presenter: Steffen Walter, CTO Immatics

Thursday, September 17, 11.05am PDT (2.05pm EDT/ 8.05pm CEST)

Session: Scaling-Up for Late Stage Trials & Commercial Capacity

Presentation: Manufacturing Platforms for Endogenous, Engineered, Autologous or Allogeneic TCR-T based Adoptive Cell Therapies

  • Extensive process development led to the manufacturing approaches for various product platforms
  • Exemplary manufacturing and/ or clinical data from various trials will be presented for the various platforms

Presenter: Ali Mohamed, VP CMC Immatics

Thursday, September 17, 12.05am PDT (3.05pm EDT/ 9.05pm CEST)
Session: Scaling-Up for Late Stage Trials & Commercial Capacity

Panel Discussion: Live Q&A with Speakers
Use this opportunity to ask your expert speakers your burning questions

John Lunger, CPSO Adaptimmune
Ali Mohamed, VP CMC Immatics
Madhusudan Peshwa, CTO Mana Therapeutics

We are looking forward to e-meeting you!

Learn more about the Hanson Wade CAR-TCR Digital Week here.


Supporting Materials